Delivering Rapid Relief.... Are You Ready?
Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.
Therapeutic blood levels attained in as early as 20 minutes.
Ready. Set. Apply. Three easy steps for administration.
We use known therapeutics with well-established safety and efficacy profiles.
Zosano Pharma’s investigational migraine treatment, M207, is a novel formulation of zolmitriptan, a drug used orally and nasally to effectively and safely treat migraines, administered via the Company’s proprietary transdermal delivery system. M207 is being investigated as a potential treatment to provide rapid relief of migraine symptoms, at any time in the migraine cycle, in a discreet and simple manner.